Proteasome inhibitors: new class of antitumor agents
The ubiquitin-proteasome pathway is the principal pathway for intracellular protein degradation1,2 (Fig 1). This pathway selectively degrades an extensive number of short-lived regulatory proteins involved in the control of normal cellular processes. In order to be degraded, proteins targeted by th...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2003-11-01
|
| Sarja: | Biomolecules & Biomedicine |
| Aiheet: | |
| Linkit: | https://www.bjbms.org/ojs/index.php/bjbms/article/view/3484 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|